Pell Tech Health Care Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 11-07-2024
- Paid Up Capital ₹ 5.00 Cr
as on 11-07-2024
- Company Age 21 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 49.75 Cr
as on 11-07-2024
- Satisfied Charges ₹ 47.32 Cr
as on 11-07-2024
- Revenue -8.07%
(FY 2023)
- Profit -18.24%
(FY 2023)
- Ebitda -7.72%
(FY 2023)
- Net Worth 13.94%
(FY 2023)
- Total Assets 15.13%
(FY 2023)
About Pell Tech Health Care
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹49.75 Cr. The company has closed loans amounting to ₹47.32 Cr, as per Ministry of Corporate Affairs (MCA) records.
Harnil Shah, Neepa Dharmesh, and Dharmesh Shah serve as directors at the Company.
- CIN/LLPIN
U24230MH2003PTC141586
- Company No.
141586
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Aug 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Pell Tech Health Care Private Limited offer?
Pell Tech Health Care Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API, Laboratory Autoclave & Sterilizers, Vertical Autoclave.
Who are the key members and board of directors at Pell Tech Health Care?
Board Members(3)
Financial Performance and Corporate Structure Insights of Pell Tech Health Care.
Pell Tech Health Care Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.07% decrease. The company also saw a substantial fall in profitability, with a 18.24% decrease in profit. The company's net worth Soared by an impressive increase of 13.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pell Tech Health Care?
In 2023, Pell Tech Health Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
2 years 8 months Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 08 Jan 2024 | ₹2.62 M | Open |
Axis Bank Limited Creation Date: 16 Dec 2022 | ₹2.00 Cr | Open |
Axis Bank Limited Creation Date: 27 Jan 2022 | ₹1.26 Cr | Open |
How Many Employees Work at Pell Tech Health Care?
Pell Tech Health Care has a workforce of 165 employees as of Apr 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Mar 31, 2016, Pell Tech Health Care has raised a total of ₹ 1.9 Cr, with the most recent deal valued at ₹ 5 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
